MedPath

Neuvizen

Registration Number: MAL12030014TC

Approved
Approval ID

07174e81b9ba5954

Registration Number

MAL12030014TC

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types4 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (4)

30Capsule CapsulesAvailable
Package Size: 30Capsule Capsules
Status: NPRA Approved
90Capsule CapsulesAvailable
Package Size: 90Capsule Capsules
Status: NPRA Approved
60Capsule CapsulesAvailable
Package Size: 60Capsule Capsules
Status: NPRA Approved
120Capsule CapsulesAvailable
Package Size: 120Capsule Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (6)

Fructus Lycium barbarum extractActive
Monograph: fructus lycium barbarum extract
Dunaliella Salina ExtractActive
Fructus Vaccinium Myrtillus ExtractActive
Monograph: fructus vaccinium myrtillus extract
Spirulina Platensis (Spirulina Powder)Active
Monograph: spirulina platensis (spirulina powder)
MARIGOLD EXTRACTActive
Haematococcus Pluvialis extractActive
Monograph: haematococcus pluvialis extract

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Neuvizen - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform